A Double-Blind, Placebo-Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine

OBJECTIVE: To determine if repetitive sphenopalatine ganglion (SPG) blocks with 0.5% bupivacaine delivered through the Tx360® are superior in reducing pain associated with chronic migraine (CM) compared with saline. BACKGROUND: The SPG is a small concentrated structure of neuronal tissue that reside...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Headache
Autors principals: Cady, Roger, Saper, Joel, Dexter, Kent, Manley, Heather R
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2015
Matèries:
Research Submissions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320756/
https://ncbi.nlm.nih.gov/pubmed/25338927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.12458
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars